¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® enzyme ÇÑ±Û È¿¼Ò
¼³¸í   
  »ý¹°Ã¼ ¼¼Æ÷¼Ó¿¡¼­ ÇÕ¼ºµÇ°í, ÁַΠ¼¼Æ÷³»¿¡¼­ ÁøÇàµÇ´Â È­ÇйÝÀÀÀ» Ã˸ÅÇϴ ´Ü¹éÁú·Î ½ÃÇè°ü³»¿¡¼­µµ °°Àº Ã˸ÅÀÛ¿ëÀ» ÇÑ´Ù. ÀÌ È¿¼Ò´Â ÀΰøÀûÀ¸·Î ¸¸µç ¾î¶² Ã˸ÅÁ¦º¸´Ù ±× Æ¯À̼º°ú Ã˸ÅÀÛ¿ëÀ̠Ź¿ùÇѠƯº°ÇÑ »ýüºÐÀÚÀÌ´Ù. ½ÅÁø´ë»ç, Áï ¼¼Æ÷³»¿¡¼­ ÀϾ´Â ¹°ÁúÀÇ È­ÇÐÀû º¯È¯Àº È¿¼ÒÀÇ ÀÛ¿ë¿¡ ÀÇÇØ ¸Å¿ì ºü¸£°í ¿øÇÒÇϰԠÀÌ·ç¾îÁø´Ù. À̰ÍÀº È¿¼ÒÀÇ Ã˸ŠȿÀ²ÀÌ ³ôÀº Á¡°ú È¿¼ÒÀÇ ±âÁú Æ¯À̼º ¶§¹®ÀÌ´Ù. È¿¼Ò¹ÝÀÀÀº »ó¿Â, »ó¾Ð, ÃÖÀû pH µî ÀûÀýÇÑ Á¶°Ç ¾Æ·¡¿¡¼­ ÁøÇàµÈ´Ù. ¶Ç È¿¼ÒÀÇ ÁÖü°¡ ´Ü¹éÁúÀ̱⠶§¹®¿¡ ´Ü¹éÁúÀ» º¯¼º½Ã۴ ¿­, °­»ê, °­¾ËÄ®¸®, À¯±â¿ë¸Å µî¿¡ ÀÇÇØ ±× ÀÛ¿ëÀ» ÀҴ´Ù. È¿¼Ò´Â »ýü¿¡ ³Î¸® ºÐÆ÷Çϸç, º¹ÀâÇÏ°í ´Ù¾çÇÑ ´ë»ç¹ÝÀÀÀ» Ã˸ÅÇϱ⠶§¹®¿¡ Á¾·ùµµ ¸¹´Ù. ¾Õ¼­ ¸»ÇÑ ¹Ù¿Í °°ÀÌ ´ëºÎºÐÀÇ È¿¼Ò´Â ¼¼Æ÷³»¿¡ Á¸ÀçÇÏÁö¸¸, Ç÷¾×°ú ±×¿ÜÀÇ °£Áú¾×¿¡ µé¾î Àֱ⵵ ÇÏ°í ¼ÒÈ­È¿¼Ò·ù󷳠ü¿Ü·Î ºÐºñµÇ´Â °Íµµ ÀÖ´Ù.
¿µ¹® enzyme-linked immunoabsorbent assay ÇÑ±Û È¿¼Ò¸é¿ªÃøÁ¤¹ý
¼³¸í   
  È¿¼Ò°áÇո鿪ÈíÂøÁ¦ °ËÁ¤¹ýÀ¸·Î ¹ø¿ªµÇ°í ÀÖ´Ù. ÀÌ ¹ýÀº Ç׿ø(¶Ç´Â Ç×ü)¿¡ ¾ËÄ®¸® Æ÷½ºÆÄŸ¾ÆÁ¦ ¶Ç´Â Æä¸£¿Á½Ãµð¾ÆÁ¦ µîÀÇ »ê¼Ò¸¦ °áÇÕ½ÃÄÑ µÎ°í ±× »ê¼ÒȰ¼ºÀ» ÁöÇ¥·Î »ï¾Æ Ç׿øÇ×ü¹ÝÀÀÀÇ Á¤µµ¸¦ ¾È ´ÙÀ½ ¿©±â¿¡¼­ Ç׿ø(¶Ç´Â Ç×ü)ÀÇ ¾çÀ» ±¸Çϴ °ÍÀÌ´Ù. ÀÌ ¹ýÀÇ ÀÌÁ¡À¸·Î¼­ °í°¨µµ, Á¶ÀÛÀÇ °£´ÜÇÔ ¹× ¹æ»ç¼±¸é¿ªÃøÁ¤¹ýó·³ ¹æ»ç¼º¹°ÁúÀ» »ç¿ëÇÏÁö ¾Ê¾Æµµ µÈ´Ù´Â Á¡À» µé ¼ö ÀÖ´Ù. È£¸£¸óÀ̳ª ¸é¿ª±Û·ÎºÒ¸°ÀÇ Á¤·®¹ýÀ¸·Î¼­ ÀÀ¿ë µÇ°í ÀÖÀ¸¸ç ÃøÁ¤¿ë Å°Æ®µµ ½ÃÆÇµÇ°í ÀÌÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • enzymotherapy
    È¿¼Ò¿ä¹ý
  • zymogen
    È¿¼Ò¿ø, Áö¸ð°Õ
  • zymogen granule
    È¿¼Ò¿ø°ú¸³
  • zymogenic cell
    È¿¼Ò¿ø¼¼Æ÷
  • enzyme precursor
    È¿¼ÒÀü±¸¹°Áú
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
  • enzymatic debridement
    È¿¼ÒÁ×ÀºÁ¶Á÷Á¦°Å(¼ú)
  • enzyme assay
    È¿¼ÒÃøÁ¤
  • enzyme labeling
    È¿¼ÒÇ¥Áö
  • enzyme labeled antibody
    È¿¼ÒÇ¥ÁöÇ×ü
  • enzymology
    È¿¼ÒÇÐ
  • enzyme-antibody conjugate
    È¿¼ÒÇ×üÁ¢ÇÕü
  • enzyme-antienzyme reaction
    È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acetylcoenzyme
    ¾Æ¼¼Æ¿Á¶È¿¼Ò
  • AST
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀü´ÞÈ¿¼Ò
  • autofermentation
    ÀÚ°¡¹ßÈ¿
  • autolytic enzyme
    ÀÚ°¡¿ëÇØÈ¿¼Ò
  • acid lipase
    »ê¼ºÁöÁúºÐÇØÈ¿¼Ò
  • acid phosphatase
    »ê¼ºÀλêºÐÇØÈ¿¼Ò
  • acylase
    ¾Æ½ÇºÐÇØÈ¿¼Ò
  • acyltransferase
    ¾Æ½ÇÀüÀÌÈ¿¼Ò
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò
  • additive effect
    ºÎ°¡È¿°ú
  • adenosine deaminase
    ¾Æµ¥³ë½ÅÅ»¾Æ¹Ì³ëÈ¿¼Ò
  • adverse effect
    À¯ÇØÈ¿°ú
  • alanine aminotransferase
    ¾Ë¶ó´Ñ¾Æ¹Ì³ëÀü´ÞÈ¿¼Ò
  • alanine transaminase
    ¾Ë¶ó´Ñ¾Æ¹Ì³ëÀü´ÞÈ¿¼Ò
  • alcohol dehydrogenase
    ¾ËÄÚ¿ÃÅ»¼ö¼ÒÈ¿¼Ò
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ELISA
    (¢¡enzyme linked immunosorbent assay) È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • efficiency
    ´É·ü, È¿À²
  • endonuclease
    ÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, ¿£µµ´ºÅ¬·¹¾ÆÁ¦
  • acetylcholine esterase
    ¾Æ¼¼Æ¿Äݸ°¿¡½ºÅ׸£ºÐÇØÈ¿¼Ò
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • inhibitory enzyme
    ¾ïÁ¦È¿¼Ò
  • inhibitory effect
    ¾ïÁ¦È¿°ú
  • oxidative enzyme
    »êÈ­È¿¼Ò
  • palliative effect
    ¿ÏÈ­È¿°ú, °æ°¨È¿°ú
  • prolonged effect
    Áö¼ÓÈ¿°ú
  • proteolytic enzyme
    ´Ü¹éÁúºÐÇØÈ¿¼Ò
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • zymotechnique
    È¿¼Ò±â¹ý-
  • enzymuria
    È¿¼Ò´¢Áõ
  • zymoprotein
    È¿¼Ò´Ü¹éÁú
  • enzyme immunoassay
    È¿¼Ò¸é¿ªºÐ¼®(¹ý)
  • enzyme-linked immunoelectrotransfer blot
    È¿¼Ò¸é¿ªÀÌÀû¹ý, È¿¼Ò¿¬°ü¸é¿ªÀü±âÀü´ÞÁ¡
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • zymogenesis
    È¿¼Ò¹ß»ý, È¿¼ÒÇü¼º
  • enzymopathy
    È¿¼Òº´Áõ
  • enzymosis
    È¿¼Ò¼º¹ßÈ¿
  • enzyme inhibition
    È¿¼Ò¾ïÁ¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • enzymotherapy
    È¿¼Ò¿ä¹ý
  • zymogen
    È¿¼Ò¿ø
  • zymogen droplet
    È¿¼Ò¿ø°ú¸³
  • zymogen granule
    È¿¼Ò¿ø°ú¸³
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • alanine aminotransferase
    ¾Ë¶ó´Ñ¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
  • alcohol dehydrogenase
    ¾ËÄÚ¿ÃÅ»¼ö¼ÒÈ¿¼Ò
  • alcohol fermentation
    ¾ËÄڿùßÈ¿
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • antagonistic effect
    ¸Â¹öÆÀÈ¿°ú, ´ëÇ×È¿°ú
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤¹ý
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • antitoxemic effect
    Ç×µ¶Ç÷ÁõÈ¿°ú
  • antitussive effect
    Ç×±âħȿ°ú, ÁøÇØÈ¿°ú
  • antiyeast substance
    Ç×È¿¸ð¹°Áú
  • ascosporogenous yeast
    ÀÚ³¶È¦¾¾»ý»êÈ¿¸ð
  • autolytic enzyme
    ÀÚ°¡¿ëÇØÈ¿¼Ò
  • cost-effectiveness analysis
    ºñ¿ëÈ¿°úºÐ¼®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ACE=> angiotensin converting enzyme
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò(ï®üµý£áÈ)
  • ACEI : angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦(ï®ü½ý£áÈåäð¤ð¥).
  • ATP-creatine-N-phosphotransferase
    »ïÀÎ»ê¾Æµ¥³ë½Å-Å©·¹¾ÆÆ¾-N-ÀÎÀüÀÌÈ¿¼Ò
  • Bernouilli effect
    º£¸£´©ÀÌ È¿°ú
  • Bohr effect
    º¸¾Æ È¿°ú(üùÍý)
  • CAI=£¾carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼ÒÀúÇØ¾à, ź»êÅ»¼öÈ¿¼ÒÀúÇØ¹°Áú.
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • CPK=£¾creatine phosphokinase
    Å©·¹¾ÆÆ¾ ÀλêÈ¿¼Ò.
  • Converting enzyme
    Àüȯȿ¼Ò(ï®üµý£áÈ)
  • Cost-effectiveness
    ºñ¿ëÈ¿À²¼º
  • Cytopath(ogen)ic effect, CPE
    ¼¼Æ÷º´º¯È¿°ú
  • DNA polymerase, RNA dependent
    RNA- ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA gyrase
    DNA ¼±È¸È¿¼Ò
  • DNA ligase
    DNA ¿¬°áÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • agonist
    È¿´É¾à(üùÒöå·), È¿ÇöÁ¦(üùúéð¥).
  • potent
    È¿·ÂÀÖ´Â, ´É·ÂÀÖ´Â.
  • yeast
    È¿¸ð(ý£Ù½), È¿¸ð±Õ(ý£Ù½Ð¶).
  • yeast
    È¿¸ð(ý£Ù½), È¿¸ð±Õ(ý£Ù½Ð¶).
  • endotrypsin
    È¿¸ð(ý£Ù½)Æ®¸³½Å.
  • torula meningitis
    È¿¸ð±Õ¼ö¸·¿°.
  • cryptococcosis
    È¿¸ð±ÕÁõ
  • cryptococcosis
    È¿¸ð±ÕÁõ(ý£Ù½Ð¶ñø)
  • cryptococcosis
    È¿¸ð±ÕÁõ.[³»°ú]Å©¸³ÅäÄÛ½ºº´.
  • cryptococcosis
    È¿¸ð±ÕÁõ.³»°úÅ©¸³ÅäÄÛ½ºº´.
  • cryptococcemia
    È¿¸ð±ÕÇ÷Áõ(ý£Ù½Ð¶úìñø)
  • phase, yeast
    È¿¸ð±â
  • yeast bread
    È¿¸ð»§.
  • yeast phase
    È¿¸ð»ó(ý£Ù½ßÓ).
  • yeast like fungus
    È¿¸ð»ó±Õ(ý£Ù½ßÒж), ÀÇ»çÈ¿¸ð±Õ(ëôÞÄý£Ù½Ð¶).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
  • aerobic fermentation
    È£±â¼º ¹ßÈ¿(¡­Û¡ý£).
  • age hardening
    ½ÃÈ¿°æÈ­(ãÁüùÌãûù).
  • agonist
    È¿´É¾à(üùÒöå·), È¿ÇöÁ¦(üùúéð¥).
  • air barrier effect
    °ø±â¸·È¿°ú(ÍöѨدüùÍý).
  • air gap effect
    °ø±â °£°Ý È¿°ú
  • alcohol dehydrogenase
    ¾ËÄÚ¿ÃÅ»¼ö¼ÒÈ¿¼Ò
  • alcohol fermentation
    ¾ËÄݼº¹ßÈ¿(¡­Û£ý£).
  • alkaline phosphatase
    ¾ËÄ«¸® ÀλêºÐÇØÈ¿¼Ò(¡­×òß«ÝÂú°ý£áÈ)
  • alkaline phosphatase
    ¾ËÄ®¸®ÀλêÈ¿¼Ò
  • alkaline phosphatase isoenzyme
    ¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦ µ¿Á¾È¿¼Ò<--À̼ҿ£ÀÚÀÓ
  • allogeneic effect
    µ¿Á¾ÀÌÇüÈ¿°ú
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò(¡­ý£áÈ).
  • ammoniacal fermentation
    ¾Ï¸ð´Ï¾Æ¹ßÈ¿ (¡­Û¡ý£).
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • ¤Ñ effect
    µ¢ÀÌÈ¿°ú, Á¾±«È¿°ú
    ðþÎÔüùÍý
  • oxidase
    »êÈ­È¿¼Ò
    ß«ûùý£áÈ
  • phosphorylase
    ÀλêÈ­È¿¼Ò
    ìÝß«ûùý£áÈ
  • ¤Ñ kinase
    ÀλêÈ­È¿¼ÒȰ¼ºÈ¿¼Ò
    ìÝß«ûùý£áÈüÀàõý£áÈ
  • placental alkaline phosphatase(PLAP)
    ŹݾËÄ®¸°ÀλêÈ¿¼Ò
    ÷ÃÚï¾ËÄ®¸°ìÝß«ý£áÈ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò»ç½½¹ÝÀÀ
    ñìùêý£áȻ罽Úãëë
  • protease
    ´Ü¹éºÐÇØÈ¿¼Ò
    Ó±ÛÜÝÂú° ý£áÈ
  • proteinase
    ´Ü¹éºÐÇØÈ¿¼Ò
    Ó±ÛÜÝÂú° ý£áÈ
  • prothrombinase
    ÇÁ·ÎÆ®·ÒºóºÐÇØÈ¿¼Ò
    ÇÁ·ÎÆ®·ÒºóÝÂú°ý£áÈ
  • reductase
    ȯ¿øÈ¿¼Ò
    ü½êªý£áÈ
  • ¤Ñ effect
    »çÀÌÆùÈ¿°ú
    »çÀÌÆùüùÍý
  • telomerase
    Á¾¸»Ã¼È¿¼Ò, Åڷθ޶ó¾ÆÁ¦
    ðûØÇô÷ý£áÈ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • enzyme amplification
    È¿¼Ò ÁõÆø(ý£áÈñòøë)
  • enzymatic activity
    È¿¼Ò Ȱ¼º (ý£áÈüÀàõ)
  • enzyme
    È¿¼Ò(ý£áÈ)
  • enzyme I
    È¿¼Ò(ý£áÈ) I
  • enzyme II
    È¿¼Ò(ý£áÈ) II
  • enzyme III
    È¿¼Ò(ý£áÈ) III
  • enzyme pH electrode
    È¿¼Ò(ý£áÈ) pH Àü±Ø(ï³Ð¿)
  • enzyme network
    È¿¼Ò(ý£áÈ) ³×Æ®¿öÅ©
  • enzyme cascade
    È¿¼Ò(ý£áÈ) ÄɽºÄÉÀ̵å
  • enzymoblotting
    È¿¼Ò(ý£áÈ)ºí·ÔÆÃ
  • enzyme assay
    È¿¼Ò(ý£áÈ)¾Æ½êÀÌ
  • enzyme-substrate complex
    È¿¼Ò-±âÁú º¹ÇÕü (ý£áÈÐñòõÜÜùêô÷)
  • enzyme-substrate intermediate
    È¿¼Ò-±âÁú Áß°£Ã¼ (ý£áÈÐñòõñéÊàô÷)
  • enzyme-substrate compound
    È¿¼Ò-±âÁú È­ÇÕ¹° (ý£áÈÐñòõûùùêÚª)
  • enzyme-inhibitor complex
    È¿¼Ò-ÀúÇØÁ¦ º¹ÇÕü (ý£áÈîÁúªð¥ÜÜùêô÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amplifier enzyme
    ÁõÆøÈ¿¼Ò(ñòøëý£áÈ)
  • anaerobic fermentation
    "Çø±â¼º¹ßÈ¿(úîѨàõ Û£ý£), ¹«»ê¼Ò¹ßÈ¿(Ùíß«áÈÛ¡ý£)"
  • analogous enzyme variants
    À¯»çÈ¿¼Ò º¯ÀÌÇü(×¾ÞÄý£áÈܨì¶úþ)
  • anti-enzyme
    Ç×È¿¼Ò(ù÷ý£áÈ)Ç×ü(ù÷ô÷)
  • antitumor enzyme
    Ç×Á¾¾ç È¿¼Ò(ù÷ðþåËý£áÈ)
  • apoenzyme
    ¾ÆÆ÷È¿¼Ò(ý£áÈ)
  • asymmetry effect
    ºÎÀçÈ¿°ú(Üôî²üùÍý)
  • atmungsferment
    È£Èí¹ßÈ¿¼Ò(Û£ý£áÈ)
  • autoradiographic efficincy
    ÀÚ°¡¹æ»çµµ¹ý(í»Ê«Û¯ÞÒÓñÛö)È¿À² (üù×Ë)
  • auxilliary enzyme
    º¸Á¶È¿¼Ò (ÜÍð¾ý£áÈ)
  • balanced fermentation
    ±ÕÇü¹ßÈ¿(гû¬Û£ý£)
  • basal enzyme
    ±âÀúÈ¿¼Ò(Ðñî¼ý£áÈ)
  • Blinks effect
    ºí¸°Å©½º È¿°ú(üùÍý) (ÔÒ) chromatic transient
  • Bohr effect
    º¸¾î È¿°ú(üùÍý)
  • bound enzyme
    °áÇÕÈ¿¼Ò(ý£áÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective half life
    À¯È¿¹Ý°¨±â
  • effective TR
    À¯È¿¹Ýº¹½Ã°£
  • entry slice effect
    À¯ÀԴܸéÈ¿°ú
  • expire
    ¼ûÀ» °ÅµÎ´Ù, Á×´Ù, À¯È¿±â°£ÀÌ Áö³ª´Ù
  • fast scan effect
    °í¼Ó½ºÄµÈ¿°ú
  • Gibbs effect
    ±é½º È¿°ú
  • gradient echo effect
    °æ»ç¿¡ÄÚÈ¿°ú
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • gradient moment nulling [=GMN]
    °æ»ç¸ð¸àÆ®¹«È¿È­
  • halo effect
    ´Þ¹«¸®È¿°ú
  • immediate effect
    Áﰢȿ°ú, Áï½ÃÈ¿°ú
  • in-flow effect
    À¯ÀÔ È¿°ú
  • iron effect
    öȿ°ú
  • lactic acid dehydrogenase
    ¶ôÆ®»êÅ»¼ö¼ÒÈ¿¼Ò
  • magnetic moment nulling
    ÀÚ±â¸ð¸àÆ®¹«È¿È­
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • E25.0
    Congenital adrenogenital disorders associated with enzyme deficiency
    È¿¼Ò°áÇ̰ú °ü·ÃµÈ ¼±Ãµ ºÎ½Å¼º±â Àå¾Ö
  • E73.0
    Congenital lactase deficiency
    ¼±Ãµ À¯´çºÐÇØÈ¿¼Ò °áÇÌÁõ
  • E73.1
    Secondary lactase deficiency
    ¼Ó¹ß¼º À¯´çºÐÇØÈ¿¼Ò °áÇÌÁõ
  • E77.0
    Defects in post-translational modification of lysosomal enzymes
    ¶óÀÌ¼Ò¼Ø È¿¼ÒÀÇ ¹ø¿ªÈÄ º¯À̰úÁ¤ÀÇ °á¼Õ
  • E80.3
    Defects of catakase and peroxidase
    īŻ¶óÁ¦ ¹× °ú»êÈ­È¿¼ÒÀÇ °á¼Õ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • yeast milk
    È¿¸ðÀ¯
  • zymonematosis
    È¿¸ðÁõ, ºÐ¾Æ±ÕÁõ
  • enzymatic defect
    È¿¼Ò °á¼ÕÁõ, È¿¼Ò °á¼Õ
  • enzymoprivic
    È¿¼Ò °áÇÌÁõÀÇ
  • enzymic antagonist
    È¿¼Ò ±æÇ×Á¦
  • enzyme immunoassay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
    ¼Ò·®ÀÌ¶óµµ ±× Ȱ¼ºÀ» °ËÃâÇÒ ¼ö ÀÖ´Â °í°¨µµÀÇ È¿¼Ò¸¦ Ç¥½ÃÀÚ·Î Çϰí Ç׿ø ȤÀº Ç×ü, ³ª¾Æ°¡¼­´Â ƯÀÌÀûÀ¸·Î ¹ÝÀÀÇÏ´Â ¹°Áú, lectin, C1q µîÀ» È­ÇÐÀûÀ¸·Î °áÇÕ½ÃÄÑ, Ç׿ø ȤÀº Ç×ü µûÀ§¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • enzyme-linked immunoadsorbent assay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
  • zymogenesis
    È¿¼Ò ¹ß»ý
  • zymasis
    È¿¼Ò ¾ÐÃâ
    ¼ö¾ÐÀ» ÀÌ¿ëÇÏ¿© È¿¸ðÀÇ À¯±â¼ººÐÀ» ÃßÃâÇÏ´Â ¹æ¹ý.
  • enzyme inhibition
    È¿¼Ò ¾ïÁ¦
  • enzymotherapy
    È¿¼Ò ¿ä¹ý
  • enzyme disorder
    È¿¼Ò Àå¾Ö
  • enzyme precursor
    È¿¼Ò Àü±¸Ã¼
  • enzymatic tag
    È¿¼Ò Ç¥Áö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅٽŠÀüȯ È¿¼Ò
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅٽŠÀüȯ È¿¼Ò
  • antitussive effect
    ÁøÇØ È¿°ú
  • artificial age-hardening
    Àΰø ½ÃÈ¿ °æÈ­
  • ascosporogenous yeast
    À¯Æ÷ÀÚ È¿¸ð, ÀÚ³¶ Æ÷ÀÚ »ý»ê È¿¸ð, ÀÚ³¶ Ȧ¾¾ »ý»ê È¿¸ð
  • assay
    Á¤·®, ¿ª°¡ °ËÁ¤, È¿·Â °ËÁ¤
    È¥ÇÕ¹°¿¡ ÀÖ´Â ¼ººÐÀÇ ¾ç, ¶Ç´Â ¾à¹°ÀÇ »ý¹°ÇÐÀû, ¾à¸®ÇÐÀû ¿ª°¡ µîÀÇ ÃøÁ¤.
  • autonomic effect
    ÀÚÀ² ½Å°æ¼º È¿°ú, ÀÚÀ² ½Å°æ È¿°ú
  • available phosphoric acid
    À¯È¿ Àλê
  • available water
    À¯È¿ ¼ö
  • balloning effect
    ÆØÃ¢ È¿°ú
  • barm
    È¿¸ð
  • Bernouilli effect
    º£¸£´©ÀÌ È¿°ú
  • bioavailabil
    »ýü ÀÌ¿ëÀ², »ýü³» ÀÌ¿ëÀ², »ýü ÀÌ¿ëÈ¿À², »ýü³» ÀÌ¿ëÈ¿À², »ýü³» À¯¿ë¼Ò
  • biological effect
    »ý¹°ÇÐÀû È¿°ú
  • blanching effect
    Ç¥¹é È¿°ú
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • efficient
    È¿°úÀÖ´Â;À¯´ÉÇÑ;´É·üÀûÀÎ
  • tellingly
    È¿°úÀûÀ¸·Î;°­·ÂÇϰÔ(forcefully)
  • effective
    È¿°úÀûÀÎ
  • efficacious
    È¿°úÀûÀÎ
  • effectual
    È¿°úÀûÀÎ;À¯È¿ÇÑ;À¯·ÂÇÑ
  • telling
    È¿°úÀûÀÎ;À¯È¿ÇÑ;ÇöÀúÇÑ;¶Ñ·ÇÇÑ;ÀλóÀûÀÎ;°¨Á¤(¼Ó»çÁ¤)À» (Àúµµ ¸ð¸£°Ô)³ªÅ¸³»´Â;µå·¯³»´Â
  • efficacy
    È¿´É; È¿Çè
  • efficacy
    È¿·Â
  • inefficaciously
    È¿·Â ¾ø´Â
  • inefficacious
    È¿·Â(È¿Çè)ÀÌ ¾ø´Â
  • inoperative
    È¿·ÂÀÌ ¾ø´Â
  • leaven
    È¿¸ð
  • yeast
    È¿¸ð
  • leaven
    È¿¸ð;´©·è;the old ~ ±¸Æó
  • microzyme
    È¿¸ð±Õ;¹ßÈ¿ ¹Ì»ý¹°
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ineffective
    ¹«È¿ÀÇ
  • ineffectiveness
    È¿°ú ¾øÀ½
  • ineffectual
    È¿°ú ¾ø´Â
  • inefficacious
    È¿°ú ¾ø´Â
  • inefficient
    È¿°ú ¾ø´Â
  • inoperative
    È¿·ÂÀÌ ¾ø´Â
  • invalidity
    ¹«È¿
  • leaven
    È¿¸ð
  • override
    (°áÁ¤À») µÚ¾þ´Ù; ¹«È¿È­ÇÏ´Ù
  • pay off
    È¿°ú°¡ ÀÖ´Ù
  • purpose
    ¸ñÀû,ÀÇÁö,È¿°ú
  • rennet
    ÀÀÀ¯ È¿¼Ò
  • repeal
    ÆóÁöÇÏ´Ù; Æó±âÇÏ´Ù; ¹«È¿·ÎÇÏ´Ù
  • rescission
    ¹«È¿·Î ÇÔ; ÆóÁö
  • telling
    È¿°ú°¡ ÀÖ´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÅëÇÕ°Ë»ö ¿Ï·á